Poly Medicure Ltd. (POLYMED) Share Price Rises 5.27% as Mid Cap Stock Gains Today
- August 11, 2026
- Posted by: Harsh Piplani
- Category: News
Poly Medicure Ltd. traded at Rs 1,866.30, up 5.27% today, taking its market capitalisation to Rs 17,152.89 crore and placing it among notable mid-cap gainers.
Poly Medicure Ltd. Share Price moved up to Rs 1,866.30 on 11 August 2026, a gain of 5.27% or Rs 93.45 from the previous close of Rs 1,772.85. With a market capitalisation of Rs 17,152.89 crore, the stock drew attention in today’s trade as a mid-cap name that cleared the relevant price rise screen tracked by Univest.
For investors looking at Poly Medicure Ltd. Share Price Today, the verified data confirms a strong same-day move, an intraday high of Rs 1,874.25 and total traded volume of 4,12,785 shares across exchanges. That combination is enough to place the stock in the day’s notable market movers, even though the supplied data does not establish any company-specific catalyst behind the move.
Why is it trending? The immediate answer is straightforward: price action was firm from the open, the stock stayed above its session low of Rs 1,776.50, and it built on that early strength through the morning. In Stock Market Today and Share Market Today discussions, such a move can push a name into the Top Gainers Today list, especially when it comes from a company with a sizeable market cap within Healthcare.
The important metrics investors can monitor next are equally clear from the data set available to Univest: whether the stock holds near its day high, whether turnover of Rs 6.97 crore sustains, how the move compares with the broader Healthcare benchmark set of 197 companies, and how its size stands against listed peers in the same sector universe. That makes this a useful Poly Medicure Ltd. Stock News update not just for intraday watchers, but also for readers tracking sector positioning and peer context.
Poly Medicure Ltd. (POLYMED) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,866.3 |
| Previous Close | Rs 1,772.85 |
| Today's Change | +Rs 93.45 (+5.27%) |
| Day Open | Rs 1,776.5 |
| Day High | Rs 1,874.25 |
| Day Low | Rs 1,776.5 |
| Current Volume (BSE) | 37,358 |
| BSE Traded Volume | 37,358 |
| NSE Traded Volume | 3,75,427 |
| Combined NSE + BSE Volume | 4,12,785 |
| Turnover | Rs 6.97 crore |
| Market Capitalisation | Rs 17,152.89 crore |
| Market Cap Category | Mid Cap |
Poly Medicure Ltd. (POLYMED) traded at Rs 1,866.3. versus the previous close of Rs 1,772.85, a rise of 5.27%. The stock opened at Rs 1,776.5, reached Rs 1,874.25, touched Rs 1,776.5. Reported volume was 37,358.
Poly Medicure Ltd. (POLYMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 17,152.89 crore |
Poly Medicure Ltd. Fundamental Analysis, based strictly on the supplied data, is less about a full company financial model and more about context. The most important verified fundamental anchor in this data set is market capitalisation: at Rs 17,152.89 crore, Poly Medicure Ltd. is substantially larger than the Healthcare sector benchmark medians and averages provided here. That does not by itself indicate quality, but it does show that today’s price rise occurred in a company that is much bigger than a typical stock in the same benchmark set.
The Healthcare benchmark includes 197 companies for market capitalisation, with a median of Rs 142.30 crore and an average of Rs 472.15 crore. The minimum in the set is Rs 4.08 crore and the maximum is Rs 3,032.97 crore. Against that backdrop, Poly Medicure Ltd. Market Cap of Rs 17,152.89 crore stands far above the benchmark’s displayed upper end. That makes the stock’s scale an important part of this Poly Medicure Ltd. Stock Analysis, because a 5.27% rise in a company of this size carries a different market significance than the same move in a very small-cap name.
There is also a useful caution in the numbers. The supplied company-specific valuation ratios such as P/E Ratio, P/B Ratio, ROE, ROCE, EPS, Book Value and Dividend Yield are not included in this data set, so the most disciplined Fundamental Analysis here is to focus on what is verifiable: company size, today’s turnover, and the sector benchmark range. In other words, today’s move is confirmed by price and participation, but a full conclusion on valuation or profitability cannot be drawn from figures that have not been supplied.
Even so, the available evidence is enough to explain investor attention. Poly Medicure Ltd. Share Price is not simply moving in a thinly traded corner of the market; it is moving in a company whose market size is large relative to the Healthcare benchmark universe shown here. That makes ownership structure less central in this case than sector and peer context, which is where investors may look next.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.7x |
| Benchmark Average P/E | 96.66x |
| Benchmark P/E Range | 3.08x to 3,396.3x |
| Benchmark Median P/B | 1.94x |
| Benchmark Median ROE | 10.92% |
| Benchmark Median ROCE | 13.38% |
| Company Market Capitalisation | Rs 17,152.89 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
Poly Medicure Ltd. (POLYMED) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
The sector backdrop shows why this move is worth tracking. Poly Medicure Ltd. sits in the Healthcare sector, and the supplied benchmark covers 197 companies in the same sector. That allows investors to place today’s price rise against a broad sector reference rather than viewing the stock in isolation.
The Healthcare benchmark data provides a wide valuation and profitability spread. Across 156 companies with P/E readings, the sector median P/E is 25.70 and the average is 96.66, with a range from 3.08 to 3,396.30. For P/B, the benchmark spans 196 companies, with a median of 1.94 and an average of 2.65, while the range runs from -16.90 to 15.98. On profitability, the same Healthcare benchmark shows median ROE of 10.92% and average ROE of 15.47% across 196 companies. Median ROCE is 13.38% and average ROCE is 17.78%.
Those figures tell two important stories. First, Healthcare is not a uniform valuation basket. The gap between the sector median P/E of 25.70 and the average of 96.66 suggests that a number of high-multiple companies skew the average upward. Second, profitability also varies widely enough that median and average numbers are both important reference points when assessing listed Healthcare names.
In market-cap terms, the benchmark scope is particularly striking. Across 197 companies, the median market capitalisation is Rs 142.30 crore and the average is Rs 472.15 crore, with the displayed maximum at Rs 3,032.97 crore. Poly Medicure Ltd. Share Price News therefore arrives against a sector frame in which the company’s Rs 17,152.89 crore market capitalisation is dramatically higher than the benchmark’s shown central tendency and even above its displayed upper bound. From a Univest perspective, that makes today’s rise notable not merely because the stock is rising today, but because it is doing so from a much larger base than most sector constituents in this benchmark universe.
The data does not establish a sector-wide trigger, but it does establish context: Poly Medicure Ltd. is part of Healthcare, and its price move is being observed in a sector where valuations, returns and company sizes vary sharply. That is why relative peer comparison becomes the next logical step in this Poly Medicure Ltd. Share Price Update.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,032.97 | 0 | 0.76 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,799.54 | 0 | 2.32 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,707.2 | 40.09 | 9.77 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,631.45 | 66.92 | 10.59 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,601.85 | 34.14 | 7.04 | -2.6 | 16.92 |
Poly Medicure Ltd. (POLYMED) has a market capitalisation of Rs 17,152.89 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Peer data shows that Poly Medicure Ltd.That means the cleanest peer read is on relative size and on how broad the peer valuation range is.
The peer basket includes companies such as Dishman Carbogen Amcis Ltd. at Rs 3,032.97 crore market cap, Hikal Ltd. at Rs 2,799.54 crore, Kwality Pharmaceuticals Ltd. at Rs 2,707.20 crore, Beta Drugs Ltd. at Rs 2,631.45 crore and Dr Agarwals Eye Hospital Ltd. at Rs 2,601.85 crore. It also includes Panacea Biotec Ltd. at Rs 2,531.49 crore, Sai Parenteral’s Ltd. at Rs 2,513.58 crore, Solara Active Pharma Sciences Ltd. at Rs 2,422.79 crore, NGL Fine-Chem Ltd. at Rs 2,118.60 crore and Venus Remedies Ltd. at Rs 2,068.61 crore. Against all of them, Poly Medicure Ltd. Market Cap of Rs 17,152.89 crore stands out clearly.
The peer numbers also highlight how mixed Healthcare financial profiles can be. Kwality Pharmaceuticals shows P/E of 40.09, P/B of 9.77, ROE of 28.21% and ROCE of 26.35%, while Beta Drugs trades at P/E of 66.92, P/B of 10.59, ROE of 18.65% and ROCE of 22.17%. NGL Fine-Chem reports ROE of 27.90% and ROCE of 33.91%. At the other end, Dishman Carbogen Amcis has P/B of 0.76 with ROE of -2.89% and ROCE of -0.26%, and Panacea Biotec shows P/B of 8.67 with ROE of 0 and ROCE of 5.36%.
That spread matters for Poly Medicure Ltd. Stock Performance analysis because it shows that peer positioning cannot be reduced to a single Healthcare template. Some peers carry high valuation multiples with strong return ratios, others show lower P/B but weak profitability, and still others sit somewhere in between. Without supplied company-specific valuation ratios for Poly Medicure Ltd., the peer conclusion that can be stated confidently is this: the company is operating from a meaningfully larger market-cap base than the comparison basket, and today’s share price gain is therefore attracting attention as a move in a large listed Healthcare name rather than a small isolated stock move.
Why Investors Are Watching Poly Medicure Ltd.
Investors are watching Poly Medicure Ltd. Share Price because today’s move combines magnitude, size and visibility. The stock gained 5.27% to Rs 1,866.30, turnover reached Rs 6.97 crore and total volume stood at 4,12,785 shares. In a market session where traders scan for Top Gainers Today and broader Market News, those figures make the stock relevant.
- Verified price action: the stock rose Rs 93.45 from Rs 1,772.85 to Rs 1,866.30, after opening at Rs 1,776.50 and touching Rs 1,874.25.
- Market-cap significance: the move came in a Mid Cap company with market capitalisation of Rs 17,152.89 crore.
- Volume participation: combined NSE and BSE volume reached 4,12,785 shares, indicating broad trading activity.
- Sector relevance: the stock belongs to Healthcare, a sector benchmark with wide spreads in valuation and profitability.
- Peer positioning: the company’s market cap is larger than every supplied peer in the comparison basket.
What should investors monitor next? The most relevant points are whether Poly Medicure Ltd. Share Price holds near today’s higher levels, whether traded participation remains firm, and whether the stock continues to feature among market movers in Healthcare. Univest would also watch how the price action evolves relative to broader sector sentiment and whether subsequent disclosures add a company-specific explanation to today’s rise.
About Poly Medicure Ltd.
Based on the supplied data, Poly Medicure Ltd. is identified within the Healthcare sector. That sector tag alone is important because it places the company inside one of the market’s most closely watched spaces for valuation, profitability and defensive-growth comparisons. In today’s Indian Stock Market, Healthcare names are often assessed not only on price action but also on how they compare with pharmaceutical and healthcare-services peers on market capitalisation and return ratios.
The benchmark and peer set supplied with this article shows that Poly Medicure Ltd. is being tracked alongside Healthcare companies such as Hikal, Kwality Pharmaceuticals, Beta Drugs, Panacea Biotec, Solara Active Pharma Sciences and NGL Fine-Chem, as well as Dr Agarwals Eye Hospital in healthcare services. That does not define Poly Medicure Ltd.’s precise business mix, but it does show the sector ecosystem in which investors are evaluating the stock.
For readers following Poly Medicure Ltd. Company News or Poly Medicure Ltd. Latest News, the most factual company profile available from this data set is therefore straightforward: it is a listed Healthcare company with a market capitalisation of Rs 17,152.89 crore, and its share price movement today has drawn attention because it occurred from a much larger base than the peer basket supplied here. As more company-specific operational or segment information becomes relevant in future data updates, that would help deepen the business overview further.
Track Poly Medicure Ltd. Share Price on Univest
Use Poly Medicure Ltd. (POLYMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors following Poly Medicure Ltd. Share Price can use Univest to track live price moves, daily change, market capitalisation, 52 Week High and 52 Week Low levels when available, shareholding pattern when disclosed, and broader market insights tied to sector and peer positioning. For users researching Poly Medicure Ltd. Share Price Today or checking Poly Medicure Ltd. Stock News, Univest helps place a single-session move in a wider context through price action, comparison frameworks and benchmark-based stock analysis.
That matters on days like this, when a stock becomes one of the visible market movers. Rather than looking only at the headline gain, readers can follow how price, volume, sector context and peer data interact over time. Univest is especially useful when investors want one place to review factual Stock Updates without turning a price rise into an unsupported forecast.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Poly Medicure Ltd. Share Price today?
Ans. Poly Medicure Ltd. Share Price was Rs 1,866.30 at the time of this update on 11 August 2026. That was Rs 93.45 above the previous close of Rs 1,772.85, translating into a 5.27% same-day gain.
Why is Poly Medicure Ltd. rising today?
Ans. The supplied data confirms that the stock is rising because it recorded a verified same-day price gain of 5.27% with total traded volume of 4,12,785 shares. However, the data set does not establish a specific company-led trigger.
How much did Poly Medicure Ltd. gain in today’s session?
Ans. Poly Medicure Ltd. gained Rs 93.45 in today’s session. The stock moved from a previous close of Rs 1,772.85 to Rs 1,866.30, which works out to a 5.27% increase on the day.
What were the day high, day low and opening price for Poly Medicure Ltd.?
Ans. The stock opened at Rs 1,776.50, which also marked the day’s low, and later rose to an intraday high of Rs 1,874.25. At the time of this article, Poly Medicure Ltd. was trading at Rs 1,866.30.
What is the market capitalisation of Poly Medicure Ltd.?
Ans. Poly Medicure Ltd. had a market capitalisation of Rs 17,152.89 crore in this update. That places it in the Mid Cap category and makes it significantly larger than the market-cap medians shown in the supplied Healthcare benchmark data.
How active was trading volume in Poly Medicure Ltd. today?
Ans. Trading activity was spread across both exchanges, with 37,358 shares on BSE and 3,75,427 shares on NSE. Combined total volume reached 4,12,785 shares, while reported turnover stood at Rs 6.97 crore.
Which sector does Poly Medicure Ltd. belong to?
Ans. Poly Medicure Ltd. belongs to the Healthcare sector based on the supplied data. That matters because the article’s benchmark comparison uses 197 companies from the same sector to place today’s price rise in context.
How does Poly Medicure Ltd.’s size compare with the Healthcare benchmark?
Ans. Its market capitalisation of Rs 17,152.89 crore is far above the Healthcare benchmark median of Rs 142.30 crore and average of Rs 472.15 crore. It is also above the benchmark’s displayed maximum company size of Rs 3,032.97 crore.
How does Poly Medicure Ltd. compare with the supplied peers by market cap?
Ans. Poly Medicure Ltd. is larger than every supplied peer by market capitalisation. The biggest peer shown is Dishman Carbogen Amcis at Rs 3,032.97 crore, well below Poly Medicure Ltd.’s Rs 17,152.89 crore market value.
What should investors monitor after this Poly Medicure Ltd. share price rise?
Ans. Investors can monitor whether the stock holds near today’s high zone after reaching Rs 1,874.25, whether turnover remains firm after Rs 6.97 crore, and whether the move continues to stand out among Healthcare market movers.